• Talking Out Loud Podcast Ep 5 | Sonjoy Brahma & Joab Williamson

  • Talking Out Loud Podcast Ep 4 | Chris Floyd & Roz Sutton

  • Talking Out Loud Podcast Ep 3 | Rienk Pypstra & Mark Lemonnier

  • Talking Out Loud Podcast Ep 2 | Rob Fox & Chris Floyd

  • Talking Out Loud Podcast Ep 1 | Rienk Pypstra & David Findlay

  • Rare Conversations podcast: Navigating the revised UK clinical trial regulations

  • Rare Conversations podcast: Will we ever have fully decentralised clinical trials in rare diseases

  • Rare Conversations podcast: The site perspective

  • Rare Conversations podcast: Reducing the patient burden

  • Rare Conversations podcast: Patient enrolment & retention

  • Rare Conversations podcast: Planning & interrogating the protocol

  • Rare Conversations podcast: Patient & regulatory acceptance

  • Rare Conversations podcast: Data collection & integrity

  • Rare Conversations podcast: Regulatory fragmentation across countries

  • Rare Conversations podcast: Four key considerations

  • Rare Conversations podcast: Patient population & challenges

  • Rare Conversations podcast: Can fully decentralised clinical trials work in the rare disease landscape?

  • Rare Conversations podcast: TMC Showcases its Associate Business Model

  • Rare Conversations podcast: TMC Discusses the Growth Opportunities in the Drug Development of Rare Diseases

  • Rare Conversations podcast: TMC’s Insights on the Future of the Rare Disease Landscape

  • Rare Conversations podcast: TMC’s Rare Disease Specialism

  • Rare Conversations podcast: TMC’s Cultural Fit & Personalised Approach

  • Rare Conversations podcast: TMC’s Legacy & Professional Expertise

  • Rare Conversations podcast: the future of the rare disease landscape with Simon Estcourt